{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Agilent Technologies, Inc.
Is Agilent Technologies, Inc. overvalued or undervalued?
As of October 17, 2025, Agilent Technologies is fairly valued with a P/E ratio of 25, lagging behind the S&P 500 with a 3.27% return over the past year, but showing stronger short-term performance with an 11.99% return in the last month.
Agilent Technologies Experiences Valuation Adjustment Amid Strong Competitive Metrics
Agilent Technologies, Inc. has recently adjusted its valuation, showcasing a P/E ratio of 25 and a Price to Book Value of 5.36. The company demonstrates strong operational performance with a notable dividend yield and competitive returns, positioning it favorably against peers in the Pharmaceuticals & Biotechnology sector.
Is Agilent Technologies, Inc. overvalued or undervalued?
As of October 17, 2025, Agilent Technologies is fairly valued with a P/E ratio of 25, an EV to EBITDA ratio of 18.73, and a Price to Book Value of 5.36, making it more attractively priced than peers like Edwards Lifesciences, despite a recent underperformance compared to the S&P 500.
Is Agilent Technologies, Inc. overvalued or undervalued?
As of October 17, 2025, Agilent Technologies, Inc. is fairly valued with a P/E ratio of 25 and competitive metrics compared to peers, despite underperforming the S&P 500 over three years while showing stronger short-term performance.
Agilent Technologies Experiences Revision in Stock Evaluation Amid Market Dynamics
Agilent Technologies, Inc. has recently revised its evaluation amid market dynamics, with its stock priced at $141.61. The company has shown notable volatility over the past year, with a 52-week high of $153.84 and a low of $96.43, while demonstrating resilience with a five-year return of 39.34%.
Agilent Technologies Forms Golden Cross, Signaling Potential Bullish Breakout
Agilent Technologies, Inc. has recently experienced a Golden Cross, signaling a potential shift in momentum. The stock's daily moving averages reflect bullish tendencies, with a notable performance increase over the past week. Despite year-to-date results lagging behind the S&P 500, recent trends suggest a possible turnaround for the company.
Is Agilent Technologies, Inc. technically bullish or bearish?
As of October 3, 2025, Agilent Technologies, Inc. shows a mildly bullish trend supported by positive MACD signals and strong recent performance compared to the S&P 500, despite lagging in longer-term returns.
Is Agilent Technologies, Inc. technically bullish or bearish?
As of October 3, 2025, Agilent Technologies, Inc. shows a mildly bullish technical trend, supported by positive weekly indicators, despite underperforming the S&P 500 over the past year and year-to-date.
Is Agilent Technologies, Inc. technically bullish or bearish?
As of October 3, 2025, Agilent Technologies, Inc. shows a mildly bullish technical trend, supported by weekly indicators, despite underperforming the S&P 500 over the past year and year-to-date.
Agilent Technologies Experiences Evaluation Revision Amid Mixed Market Signals and Performance Trends
Agilent Technologies, Inc. has recently revised its evaluation amid fluctuating market conditions. The stock is priced at $123.39, reflecting a slight increase. Over the past year, Agilent has faced a decline of 15.91%, contrasting with the S&P 500's gain. Mixed technical indicators suggest varying market sentiments.
Agilent Technologies Experiences Revision in Stock Evaluation Amid Mixed Market Signals
Agilent Technologies, Inc. has recently seen a stock price of $126.32, reflecting notable volatility with a 52-week range of $96.43 to $153.84. Technical indicators present mixed signals, while the company has outperformed the S&P 500 over the past week and month, but lags year-to-date and over five years.
Is Agilent Technologies, Inc. technically bullish or bearish?
As of July 24, 2025, Agilent Technologies, Inc. exhibits a mildly bearish trend, with daily moving averages indicating bearishness, while it has underperformed the S&P 500 with a year-to-date return of -5.00% compared to the S&P's 12.22%.
Is Agilent Technologies, Inc. overvalued or undervalued?
As of July 7, 2025, Agilent Technologies is fairly valued with a P/E ratio of 25, making it more attractive than peers like Edwards Lifesciences and DexCom, despite its year-to-date return of -5.00% lagging behind the S&P 500's 12.22%.
Is Agilent Technologies, Inc. overvalued or undervalued?
As of May 28, 2025, Agilent Technologies is fairly valued with a P/E ratio of 25 and an EV to EBITDA ratio of 18.73, but its stock has underperformed the S&P 500 with a year-to-date return of -13.56%.
Is Agilent Technologies, Inc. technically bullish or bearish?
As of May 27, 2025, Agilent Technologies, Inc. shows a mildly bearish trend due to daily moving averages and monthly Bollinger Bands, despite some mildly bullish signals from the weekly MACD, with a year-to-date return of -13.56% against the S&P 500.
Who are in the management team of Agilent Technologies, Inc.?
As of March 2022, Agilent Technologies, Inc.'s management team includes Non-Executive Independent Chairman Boon Hwee Koh, President and CEO Michael McMullen, and Independent Directors Mala Anand, Hans Bishop, Paul Clark, and Heidi Kunz. They oversee the company's strategic direction and governance.
What does Agilent Technologies, Inc. do?
Agilent Technologies, Inc. offers application-focused solutions for laboratory workflows in the Pharmaceuticals & Biotechnology industry, with recent net sales of $1.668 billion and a market cap of approximately $32.98 billion. Key financial metrics include a P/E ratio of 25.00 and a dividend yield of 64.19%.
How big is Agilent Technologies, Inc.?
As of Jun 18, Agilent Technologies, Inc. has a market capitalization of $32.98 billion, with net sales of $6.63 billion and net profit of $1.17 billion over the latest four quarters.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
